DK1248650T3 - Enhanced bovine herpes virus DNA vaccines 1 - Google Patents

Enhanced bovine herpes virus DNA vaccines 1

Info

Publication number
DK1248650T3
DK1248650T3 DK01907651T DK01907651T DK1248650T3 DK 1248650 T3 DK1248650 T3 DK 1248650T3 DK 01907651 T DK01907651 T DK 01907651T DK 01907651 T DK01907651 T DK 01907651T DK 1248650 T3 DK1248650 T3 DK 1248650T3
Authority
DK
Denmark
Prior art keywords
herpes virus
dna vaccines
virus dna
bovine herpes
enhanced
Prior art date
Application number
DK01907651T
Other languages
Danish (da)
Inventor
Laurent Bernard Fischer
Jean-Christophe Franc Audonnet
Simona Barzu-Le-Roux
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of DK1248650T3 publication Critical patent/DK1248650T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK01907651T 2000-01-21 2001-01-19 Enhanced bovine herpes virus DNA vaccines 1 DK1248650T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000798A FR2804028B1 (en) 2000-01-21 2000-01-21 IMPROVED DNA VACCINES FOR PENSION ANIMALS
PCT/FR2001/000187 WO2001052888A2 (en) 2000-01-21 2001-01-19 Improved dna vaccines for production-type animals

Publications (1)

Publication Number Publication Date
DK1248650T3 true DK1248650T3 (en) 2007-04-16

Family

ID=8846183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01907651T DK1248650T3 (en) 2000-01-21 2001-01-19 Enhanced bovine herpes virus DNA vaccines 1

Country Status (21)

Country Link
EP (1) EP1248650B1 (en)
JP (1) JP2004500375A (en)
KR (1) KR100820893B1 (en)
CN (2) CN1404398B (en)
AR (1) AR027926A1 (en)
AT (1) ATE346611T1 (en)
AU (1) AU783865B2 (en)
BR (2) BRPI0107767B1 (en)
CA (1) CA2398229C (en)
CY (1) CY1107627T1 (en)
DE (1) DE60124862T2 (en)
DK (1) DK1248650T3 (en)
ES (1) ES2277913T3 (en)
FR (1) FR2804028B1 (en)
HU (1) HU229597B1 (en)
MX (1) MXPA02007110A (en)
NZ (1) NZ520270A (en)
PL (1) PL209304B1 (en)
PT (1) PT1248650E (en)
WO (1) WO2001052888A2 (en)
ZA (1) ZA200205698B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
PT2311848E (en) 2002-12-23 2013-10-03 Vical Inc Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
EP1594537B1 (en) * 2003-02-19 2012-10-24 Merial Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3
MXPA06005424A (en) 2003-11-13 2007-01-25 Univ Georgia Res Found Methods of characterizing infectious bursal disease virus.
CU23544A1 (en) 2006-02-28 2010-06-17 Ct Ingenieria Genetica Biotech CHEMICAL VACCINAL ANTIGENS AGAINST THE CLASSICAL SWINE VIRUS VIRUS
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
RU2585961C9 (en) * 2009-05-22 2016-12-27 Дженосеа Биосайенсиз Инк. Vaccine against herpes simplex virus type 2: compositions and methods for triggering immune response
WO2012065286A1 (en) * 2010-11-19 2012-05-24 北京凯因科技股份有限公司 Composition of dna vaccine for preventing and treating hepatitis b
CN112034169A (en) * 2020-08-27 2020-12-04 华威特（江苏）生物制药有限公司 Direct immunofluorescence reagent for detecting bovine viral diarrhea virus type 1 and kit thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07504683A (en) * 1992-07-08 1995-05-25 シェリング・コーポレーション Use of GM-CSF as a vaccine adjuvant
EP0702516A4 (en) * 1993-06-01 1998-04-22 Life Technologies Inc Genetic immunization with cationic lipids
US5658785A (en) * 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
EP0779923A2 (en) * 1994-09-09 1997-06-25 Neurocrine Biosciences, Inc. Interleukin-1 type 3 receptors
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5719131A (en) * 1994-12-09 1998-02-17 Genzyme Corporation Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
JPH11504631A (en) * 1995-04-25 1999-04-27 バイカル インコーポレイテッド Single vial formulation of DNA / lipid complex
CA2220950A1 (en) * 1995-05-26 1996-11-28 Somatix Therapy Corporation Delivery vehicles comprising stable lipid/nucleic acid complexes
FR2751228B1 (en) * 1996-07-19 1998-11-20 Rhone Merieux BOVINE POLYNUCLEOTIDE VACCINE FOR INTRADERMAL ROUTE
FR2751229B1 (en) * 1996-07-19 1998-11-27 Rhone Merieux POLYNUCLEOTIDE VACCINE FORMULA IN PARTICULAR AGAINST RESPIRATORY PATHOLOGY OF CATTLE
FR2751224B1 (en) * 1996-07-19 1998-11-20 Rhone Merieux POLYNUCLEOTIDE VACCINE FORMULA AGAINST BREATHING AND PIG REPRODUCTIVE CONDITIONS
WO1998040499A1 (en) * 1997-03-10 1998-09-17 Heather Lynn Davis Gene delivery to mucosal epithelium for immunization or therapeutic purposes
AUPO856097A0 (en) * 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
KR100768114B1 (en) * 1999-06-10 2007-10-17 메리알 Dna vaccines for pets and sport animals
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV

Also Published As

Publication number Publication date
MXPA02007110A (en) 2003-01-28
FR2804028A1 (en) 2001-07-27
EP1248650A2 (en) 2002-10-16
CY1107627T1 (en) 2013-04-18
ES2277913T3 (en) 2007-08-01
WO2001052888A3 (en) 2001-12-20
KR100820893B1 (en) 2008-04-10
HU229597B1 (en) 2014-02-28
KR20020084093A (en) 2002-11-04
JP2004500375A (en) 2004-01-08
NZ520270A (en) 2004-08-27
BR0107767A (en) 2002-11-12
AU3556601A (en) 2001-07-31
CA2398229A1 (en) 2001-07-26
PL209304B1 (en) 2011-08-31
EP1248650B1 (en) 2006-11-29
CN1404398B (en) 2012-05-02
HUP0203974A2 (en) 2003-03-28
ZA200205698B (en) 2003-09-29
AR027926A1 (en) 2003-04-16
FR2804028B1 (en) 2004-06-04
AU783865B2 (en) 2005-12-15
PL356554A1 (en) 2004-06-28
ATE346611T1 (en) 2006-12-15
DE60124862T2 (en) 2007-07-05
PT1248650E (en) 2007-02-28
CN1404398A (en) 2003-03-19
DE60124862D1 (en) 2007-01-11
BRPI0107767B1 (en) 2017-10-24
CN101554480A (en) 2009-10-14
CA2398229C (en) 2012-05-15
WO2001052888A2 (en) 2001-07-26
HUP0203974A3 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
CY2016020I1 (en) HERPES VIRUS STRAIN FOR GENE THERAPY
DK1058558T3 (en) Recombinant and adjuvanted influenza and herpes virus vaccines
GB2337755B (en) Virus vaccine
NO20003302D0 (en) Vaccine
ZA975619B (en) Recombinant live vaccine based on canine herpesvirus in particular against carre's disease rabies or the para-influenza virus type 2
HK1046243B (en) Aids virus vaccines using sendai virus vector
NO20014322D0 (en) Vaccine
AU4932601A (en) Recombinant parainfluenza virus expression systems and vaccines
DE60002650D1 (en) Oil-vaccinated vaccine
MA25489A1 (en) VACCINES
FR2776928B1 (en) ADJUVATED DNA VACCINES
DK1248650T3 (en) Enhanced bovine herpes virus DNA vaccines 1
EP1204424A4 (en) Recombinant rsv virus expression systems and vaccines
DK1372712T3 (en) Vaccine against equine herpes virus
ATE519775T1 (en) RECOMBINANT SUBUNIT VACCINES
HUP0200560A2 (en) Bhv-1 gene-deleted virus vaccine
ATE295182T1 (en) COMPOSITIONS FOR IMMUNO-BOOSTING VACCINES
EP1490396A4 (en) Immunogenic hiv peptides for use as reagents and vaccines
IS2797B (en) Vaccine against ISA virus
HUP0002908A2 (en) Recombinant newcastle disease virus as embryo vaccine
EP1296710A4 (en) Recombinant vaccines against infectious bursal disease virus
SI1155119T1 (en) Bhv-1 gene-deleted virus vaccine
GB9917981D0 (en) Viral vaccine
GB9826647D0 (en) DNA vaccines
NO20002213D0 (en) Babesia vaccine